Robert E Bristow

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
    Jianghong Li
    Laboratory of Cellular and Molecular Biology, National Institute on Aging, Baltimore, MD, USA
    BMC Cancer 9:244. 2009
  2. ncbi Analysis of contemporary trends in access to high-volume ovarian cancer surgical care
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 16:3422-30. 2009
  3. ncbi Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics and Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 115:334-8. 2009
  4. ncbi Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009
  5. ncbi Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 NorthWolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 109:364-9. 2008
  6. ncbi Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
  7. ncbi Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:746-52. 2011
  8. ncbi Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
    Edward J Tanner
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 117:336-40. 2010
  9. ncbi Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1043-7. 2006
  10. ncbi Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:685-91. 2007

Detail Information

Publications93

  1. ncbi Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
    Jianghong Li
    Laboratory of Cellular and Molecular Biology, National Institute on Aging, Baltimore, MD, USA
    BMC Cancer 9:244. 2009
    ..Here, we have explored the possible use of these proteins as screening biomarkers for ovarian cancer detection...
  2. ncbi Analysis of contemporary trends in access to high-volume ovarian cancer surgical care
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Ann Surg Oncol 16:3422-30. 2009
    ..However, contemporary patterns of primary surgical care for ovarian cancer according to hospital and surgeon case volume remain poorly defined...
  3. ncbi Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics and Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 115:334-8. 2009
    ..To evaluate the impact of surgeon and hospital case volume, and other related variables, on short-term outcomes after surgery for ovarian cancer...
  4. ncbi Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, MD 21287, USA
    Gynecol Oncol 114:173-7. 2009
    ..To describe the operative technique and associated clinical outcomes of patients undergoing rectosigmoid colectomy as a component of secondary cytoreductive surgery for recurrent ovarian cancer...
  5. ncbi Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 NorthWolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 109:364-9. 2008
    ..To describe the operative techniques and associated clinical outcomes of patients undergoing transverse colectomy as a component of cytoreductive surgery for advanced or recurrent ovarian cancer...
  6. ncbi Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 106:476-81. 2007
    ..To evaluate the cost-effectiveness of intraperitoneal cisplatin and paclitaxel chemotherapy as front-line treatment for patients with Stage III epithelial ovarian cancer following optimal primary cytoreductive surgery...
  7. ncbi Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:746-52. 2011
    ..To evaluate the impact of surgeon and hospital case volume and other related variables on short-term outcomes after surgery for oropharyngeal cancer...
  8. ncbi Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
    Edward J Tanner
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 117:336-40. 2010
    ....
  9. ncbi Uterine cancer in Maryland: impact of surgeon case volume and other prognostic factors on short-term mortality
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1043-7. 2006
    ..To characterize the patterns of primary surgical care and short term outcomes for uterine cancer according to surgeon and hospital case volume...
  10. ncbi Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:685-91. 2007
    ....
  11. ncbi Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe St Phipps 281, Baltimore, Maryland 21224, USA
    Ann Surg Oncol 14:3552-7. 2007
    ....
  12. ncbi Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 90:519-28. 2003
    ....
  13. ncbi Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 22:273-9. 2012
    ..The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I noninvasive or minimally invasive (≤3 mm) uterine serous carcinoma (USC)...
  14. ncbi Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:294-300. 2005
    ..To evaluate the utility of combined positron emission tomography/computed tomography (PET/CT) for detecting recurrent epithelial ovarian cancer limited to retroperitoneal adenopathy...
  15. ncbi Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range
    Antonio Santillan
    Kelly Gynecology Oncology Service, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Clin Oncol 23:9338-43. 2005
    ..To evaluate the risk of epithelial ovarian cancer (EOC) recurrence in patients with rising serum cancer antigen 125 (CA-125) levels that remain below the upper limit of normal (< 35 U/mL)...
  16. ncbi Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Gynecol Oncol 109:388-93. 2008
    ..S. healthcare system of implementing a clinical pathway for Pap test utilization in screening and surveillance of gynecologic cancers in a university-based gynecologic oncology practice...
  17. ncbi Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93
    Stefanie M Ueda
    Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Am J Pathol 175:2618-24. 2009
    ..FASN inhibitors such as C93 warrant further investigation as targeted therapeutic agents for metastatic and chemoresistant gestational trophoblastic neoplasia...
  18. ncbi Recurrent micropapillary serous ovarian carcinoma
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1246, USA
    Cancer 95:791-800. 2002
    ....
  19. ncbi A clinical pathway for patients undergoing primary cytoreductive surgery with rectosigmoid colectomy for advanced ovarian and primary peritoneal cancers
    Melissa A Gerardi
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 108:282-6. 2008
    ....
  20. ncbi Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Cancer 109:1513-22. 2007
    ..The objective of this study was to evaluate the cost-effectiveness of centralized referral of patients with advanced-stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy...
  21. ncbi Surgical care of young women diagnosed with ovarian cancer: a population-based perspective
    Edward J Tanner
    Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, USA
    Gynecol Oncol 111:221-5. 2008
    ..To characterize primary surgical care for women with ovarian cancer aged </=50 years versus > 50 years...
  22. ncbi Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor
    Martina Bazzaro
    Department of Pathology, The Johns Hopkins University, Baltimore, Maryland 21231, USA
    Clin Cancer Res 14:7340-7. 2008
    ....
  23. ncbi Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement
    Kara Judson
    Department of Pathology, School of Public Health, The Johns Hopkins University, Baltimore, Maryland, USA
    Int J Gynecol Pathol 27:182-90. 2008
    ....
  24. ncbi Clinical significance of Her-2/neu overexpression in uterine serous carcinoma
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Gynecol Oncol 100:139-44. 2006
    ..To evaluate the clinico-pathologic characteristics and survival outcome associated with overexpression of Her-2/neu in patients with uterine serous carcinoma (USC)...
  25. ncbi Ovarian cancer surgery in Maryland: volume-based access to care
    Robert E Bristow
    Department of Biostatistics, Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 93:353-60. 2004
    ..To characterize the patterns of primary surgical care for ovarian cancer in a statewide population according to annual surgeon and hospital case volume...
  26. ncbi Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 104:739-46. 2007
    ....
  27. ncbi PET-CT in recurrent ovarian cancer: initial observations
    Harpreet K Pannu
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 600 N Wolfe St, Baltimore, MD 21287, USA
    Radiographics 24:209-23. 2004
    ..Combined functional-anatomic imaging can also increase diagnostic confidence at CT. Further study is needed to determine the possible benefits of lesion conspicuity at PET and anatomic localization at CT on fused PET-CT scans...
  28. ncbi Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer
    Hannah H Alphs
    The Johns Hopkins School of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1048-53. 2006
    ..Perioperative variables such as these can be used to identify the elderly patients that are most likely to be suboptimally cytoreduced and thus have a dismal survival outcome...
  29. ncbi The role of cytoreductive surgery for colon cancer metastatic to the ovary
    Colleen C McCormick
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Gynecol Oncol 105:791-5. 2007
    ..We sought to further elucidate the survival impact of cytoreductive surgery among patients with colon cancer metastatic to the ovary...
  30. ncbi Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 104:686-90. 2007
    ..To evaluate the feasibility and associated survival outcome of secondary cytoreductive surgery in patients with isolated lymph node recurrence of epithelial ovarian cancer...
  31. ncbi Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Gynecol Oncol 106:82-8. 2007
    ..To identify effective treatment options for patients with recurrent uterine leiomyosarcoma (LMS)...
  32. ncbi Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 103:709-13. 2006
    ..To examine the cost-effectiveness of routine vaginal cytology in detecting asymptomatic isolated vaginal recurrence during post-treatment endometrial cancer surveillance...
  33. ncbi Concentration of uterine cancer surgical care among the elderly: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 107:436-40. 2007
    ..To characterize the primary surgical care and short-term outcomes for uterine cancer in women age > or = 80 years compared to younger women...
  34. ncbi Salvage cytoreductive surgery for recurrent endometrial cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 103:281-7. 2006
    ..To determine the survival impact of salvage cytoreductive surgery, and other prognostic variables, among patients with recurrent endometrial cancer...
  35. ncbi The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Gynecol Oncol 118:262-7. 2010
    ..To examine the effect of hospital procedure volume and other prognostic variables on overall survival outcome and likelihood of receiving standard recommended care among patients with advanced-stage epithelial ovarian cancer...
  36. ncbi Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, Maryland 21287, USA
    Anticancer Res 29:2875-84. 2009
    ..To identify immunosuppressive elements present in ovarian cancer associated ascites...
  37. ncbi p53 autoantibodies, cytokine levels and ovarian carcinogenesis
    Miyun Tsai-Turton
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Gynecol Oncol 114:12-7. 2009
    ..To address the hypothesis that type II ovarian carcinoma, mutation of p53 and plasma levels of particular cytokines are associated with the generation of p53-specific serum autoantibody (AAb) responses in patients...
  38. ncbi Surgical care of elderly women with ovarian cancer: a population-based perspective
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 99:352-7. 2005
    ..To characterize the primary surgical care and short-term outcomes for ovarian cancer in women aged 80 years and older compared to women younger than 80 years...
  39. ncbi Expression of extracellular matrix proteins in ovarian serous tumors
    Ritu Salani
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
    Int J Gynecol Pathol 26:141-6. 2007
    ..007). In summary, ovarian carcinomas exhibit up-regulated expression of several extracellular matrix proteins, and syndecan 1 represents a novel tumor-associated marker in ovarian serous carcinomas...
  40. ncbi Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 107:495-9. 2007
    ..To evaluate clinicopathological factors and survival outcome of patients with advanced epithelial ovarian carcinoma undergoing multiple bowel resections to achieve optimal (< or = 1 cm) cytoreduction...
  41. ncbi Comparison of candidate serologic markers for type I and type II ovarian cancer
    Dan Lu
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
    Gynecol Oncol 122:560-6. 2011
    ..To examine the value of individual and combinations of ovarian cancer associated blood biomarkers for the discrimination between plasma of patients with type I or II ovarian cancer and disease-free volunteers...
  42. ncbi Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer
    Shazia Bashir
    The Kelly Gynecology and Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 119:255-8. 2010
    ..To describe the technique and short-term post-operative outcomes associated with diaphragm full-thickness resection (FTR) and intraoperative trans-diaphragmatic decompression of the resultant pneumothorax (TDDP)...
  43. ncbi Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers
    Lauren S Krill
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 120:220-3. 2011
    ..To evaluate the risk of postoperative complications related to HA-CMC use in patients undergoing optimal cytoreductive surgery for primary and recurrent ovarian, fallopian tube, and peritoneal cancers...
  44. ncbi Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET
    Mitsuaki Tatsumi
    Division of Nuclear Medicine, Department of Radiology, Johns Hopkins Medical Institutions, 601 North Caroline Street, Baltimore, MD 21287 0817, USA
    Mol Imaging Biol 11:229-35. 2009
    ....
  45. ncbi Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian cancer: a pilot study
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Clin Imaging 34:191-5. 2010
    ..The objective of this study was to utilize computed tomographic peritoneography (CTP) to assess distribution prior to intraperitoneal chemotherapy for advanced müllerian cancer...
  46. ncbi Volume-based trends in surgical care of patients with oropharyngeal cancer
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Laryngoscope 121:738-45. 2011
    ..Positive volume-outcome relationships exist for diseases treated with technically complex surgery. Contemporary patterns of oropharyngeal cancer surgery by hospital and surgeon volume are poorly defined...
  47. ncbi Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Adolesc Health 39:411-6. 2006
    ....
  48. ncbi Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer
    Ritu Salani
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Gynecol Oncol 108:271-5. 2008
    ....
  49. ncbi Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results
    Teresa P Diaz Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 104:366-71. 2007
    ..To determine the utility of the category of atypical glandular cells (AGC) in the management of patients with putative cervical neoplasia and to correlate HPV-DNA test results when available...
  50. ncbi Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    J Am Coll Surg 197:565-74. 2003
    ..The associated morbidity is acceptable, and protective intestinal diversion appears unnecessary...
  51. ncbi Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis
    Joyce N Barlin
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, 600 North Wolfe St, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 118:14-8. 2010
    ..To determine the relative effect and quantify the impact of multiple prognostic variables on median overall survival time among cohorts of patients with advanced or recurrent endometrial cancer undergoing cytoreductive surgery...
  52. ncbi Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 98:510-2. 2005
    ..Combined positron emission tomography (PET) and computed tomography (CT) may have a potential role in the early detection and anatomical localization of recurrent ovarian cancer...
  53. ncbi A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival
    Kentaro Nakayama
    Department of Pathology, Johns Hopkins Medical Institutions, 1550 Orleans Street, Baltimore, MD 21231, USA
    Proc Natl Acad Sci U S A 103:18739-44. 2006
    ....
  54. ncbi Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 107:464-8. 2007
    ....
  55. ncbi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
    Robert E Bristow
    Department of Gynecology, The Kelly Gynecologic Oncology Service, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 112:265-74. 2009
    ..To determine the relative effect of multiple prognostic variables on overall post-recurrence survival time among cohorts of patients with recurrent ovarian cancer undergoing cytoreductive surgery...
  56. ncbi Evaluation and management of adnexal masses during pregnancy
    Robert L Giuntoli
    Hopkins Medical Institutions, Phipps 281, Baltimore, Maryland 21287, USA
    Clin Obstet Gynecol 49:492-505. 2006
    ..In the approximately 5% of cases in which an adnexal masses proves to be a malignancy, appropriate staging may be safely performed. In selected cases, chemotherapy should at least be entertained...
  57. ncbi A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study
    Deborah K Armstrong
    Johns Hopkins Kimmel Cancer Center, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231 1000, USA
    Gynecol Oncol 105:667-71. 2007
    ....
  58. ncbi Abdominal carcinomatosis in women with a history of breast cancer
    Ruchi Garg
    Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Baltimore, MD 21287-1281, USA
    Gynecol Oncol 99:65-70. 2005
    ..Optimal cytoreductive surgery was associated with a significant survival advantage for patients with primary ovarian/peritoneal cancer...
  59. ncbi Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility
    Martina Bazzaro
    Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Am J Pathol 171:1640-9. 2007
    ..In sum, these findings implicate elevated GC UNC-45 protein expression in ovarian carcinoma proliferation and metastasis...
  60. ncbi Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 104:480-90. 2007
    ..To summarize the existing data on interval cytoreductive surgery and neoadjuvant chemotherapy as alternative treatment strategies for patients with advanced-stage ovarian cancer...
  61. ncbi Micropapillary serous ovarian carcinoma: surgical management and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 86:163-70. 2002
    ....
  62. ncbi Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 96:753-9. 2005
    ..To evaluate the demographic characteristics, clinico-pathological features, and patterns of care of uterine cancer among Hispanic women living in the United States...
  63. ncbi Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 103:1070-6. 2006
    ..To determine the overall survival and relative effect of multiple prognostic variables in cohorts of patients with advanced-stage ovarian cancer treated with platinum-based neoadjuvant chemotherapy in lieu of primary cytoreductive surgery...
  64. ncbi Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors
    Marcela G del Carmen
    Department of Gynecology and Obstetrics Department of Oncology, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland, USA
    Cancer 98:1658-63. 2003
    ..Using immunohistochemical methods, we compared the differential expression patterns of various cytokines and growth factors in atypical endometriosis (AE) and EAOC...
  65. ncbi Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review
    Okechukwu A Ibeanu
    Division of Gynecologic Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
    Int J Gynecol Cancer 20:S1-11. 2010
    ..Clinicopathological and radiological models for predicting optimal resectability have not been universally applicable...
  66. ncbi Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia
    Joyce N Barlin
    Department of Gynecology and Obstetrics, Johns Hopkins Hospital, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    J Reprod Med 55:129-33. 2010
    ..To determine the utility of endocervical curettage (ECC) at cervical conization for predicting residual or recurrent dysplasia and to evaluate differences in management between general gynecologists and gynecologic oncologists...
  67. ncbi Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature
    Joyce N Barlin
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Womens Health (Lond Engl) 5:403-11. 2009
    ....
  68. ncbi Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD 21287 1248, USA
    J Clin Oncol 20:1248-59. 2002
    ..To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy...
  69. ncbi Uterine leiomyosarcoma: present management
    Robert L Giuntoli
    The Kelly Gynecologic Oncology Service, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Curr Opin Oncol 16:324-7. 2004
    ..To review current investigations impacting management of uterine leiomyosarcoma (LMS)...
  70. ncbi Argon beam coagulation facilitates management of placenta percreta with bladder invasion
    Amer K Karam
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287, USA
    Obstet Gynecol 102:555-6. 2003
    ..Placenta percreta with bladder invasion is a rare but potentially lethal complication of pregnancy...
  71. ncbi Multidetector CT of peritoneal carcinomatosis from ovarian cancer
    Harpreet K Pannu
    Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287, USA
    Radiographics 23:687-701. 2003
    ..Interactive multiplanar review of the abdomen and pelvis has the potential to improve detection of peritoneal metastases at CT...
  72. ncbi Volume-based trends in thyroid surgery
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins University, 601 N Caroline St, Ste 6260, Baltimore, MD 21287, USA
    Arch Otolaryngol Head Neck Surg 136:1191-8. 2010
    ..to characterize contemporary patterns of thyroid surgical care and variables associated with access to high-volume care...
  73. ncbi Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institution, Baltimore, Maryland 21287, USA
    Gynecol Oncol 85:196-200. 2002
    ....
  74. ncbi A practical framework for patient care teams to prospectively identify and mitigate clinical hazards
    Kurt R Herzer
    Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, USA
    Jt Comm J Qual Patient Saf 35:72-81. 2009
    ....
  75. ncbi Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:301-8. 2005
    ....
  76. ncbi Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status
    Ritu Salani
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State Medical Center, Columbus, OH 43210, USA
    Am J Obstet Gynecol 200:182.e1-5. 2009
    ..We sought to determine the value of conization margin status in predicting residual and recurrent adenocarcinoma in situ (ACIS) of the cervix...
  77. ncbi Primary insular carcinoid of the ovary
    Teresa P Diaz-Montes
    Department of Gynecology and Obstetrics, The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 101:175-8. 2006
    ..Thus, there appears to be a good correlation between the size of the tumor and the presence of the carcinoid syndrome...
  78. ncbi Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    C William Helm
    Division of Gynecologic Oncology, James Graham Brown Cancer Center, University of Louisville, Kentucky 40207, USA
    J Surg Oncol 98:283-90. 2008
    ....
  79. ncbi Explained compared with unexplained fever in postoperative myomectomy and hysterectomy patients
    Eli A Rybak
    Division of Reproductive Endocrinology and Infertility and the Department of Epidemiology and Population Health, Albert Einstein College of Medicine Montefiore Medical Center, Bronx, New York 10461, USA
    Obstet Gynecol 111:1137-42. 2008
    ..To confirm that fever with localized findings is less prevalent among febrile postoperative myomectomy patients than it is among hysterectomy patients...
  80. ncbi Surgery for ovarian cancer: how to improve survival
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Lancet 367:1558-60. 2006
  81. ncbi Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome
    Amer K Karam
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:377-80. 2007
    ..We sought to evaluate the impact of TCS on survival and to determine predictors of optimal tertiary resection...
  82. ncbi Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer
    Allison E Axtell
    University of California Los Angeles UCLA Medical Center, Los Angeles, CA, USA
    J Clin Oncol 25:384-9. 2007
    ..Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C...
  83. ncbi Gynecologic abnormalities in surgically treated women with stage II or III rectal cancer
    Sven O Becker
    The Kelly Gynecologic Oncology Service, Departments of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, Baltimore, MD 21287, USA
    J Am Coll Surg 194:315-23. 2002
    ..The utilization of prophylactic oophorectomy in postmenopausal women undergoing surgery for rectal cancer is currently not optimal; preoperative discussion should address this option...
  84. ncbi Ovarian cancer in elderly women
    Nicholas C Lambrou
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami, School of Medicine, Miami, Florida, USA
    Oncology (Williston Park) 17:1075-81; discussion 1081, 1085-6, 1091. 2003
    ..In addition, enhanced cooperation between geriatricians and oncologists may assist the pretreatment assessment of elderly patients and improve treatment guidelines in this population...
  85. ncbi Predicting "unresectable" ovarian cancer: Taking aim at a moving target
    Robert E Bristow
    Gynecol Oncol 100:449-50. 2006
  86. ncbi Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
    Craig C Earle
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Cancer Inst 98:172-80. 2006
    ..e., better outcomes). We examined associations between physician specialty and outcomes in a population-based cohort of elderly ovarian cancer surgery patients...
  87. ncbi Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection
    Deborah Schrag
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Natl Cancer Inst 98:163-71. 2006
    ..e., hospital or surgeon) procedure volumes and patient outcomes have been demonstrated for many types of cancer operation. We performed a population-based cohort study to examine these associations for ovarian cancer resections...
  88. ncbi Secondary cytoreductive surgery for isolated nodal recurrence of ovarian cancer
    Robert E Bristow
    Ann Surg Oncol 11:639-40. 2004
  89. ncbi Role of obesity in the surgical management of advanced-stage ovarian cancer
    Adam J Wolfberg
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Reprod Med 49:473-6. 2004
    ....
  90. ncbi Stage IV micropapillary serous ovarian carcinoma: a report of three cases
    Yong-Wook Kim
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Int J Gynecol Pathol 24:235-8. 2005
    ..These cases demonstrate the potential of MPSCs for aggressive clinical behavior and distant metastases...
  91. ncbi Secondary cytoreduction for patients with recurrent ovarian cancer
    Teresa P Diaz-Montes
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Curr Oncol Rep 7:451-8. 2005
    ..A clear understanding of the prognostic factors and expectations from the procedure are necessary in order to identify candidates adequately...
  92. ncbi A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model
    Giovanni D Aletti
    Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gynecol Oncol 107:99-106. 2007
    ..To test the feasibility and utility of a risk-adjusted, multicenter outcomes model for ovarian cancer surgery as a tool for quality improvement...
  93. ncbi Uterine cancers
    Benjamin E Greer
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA, USA
    J Natl Compr Canc Netw 4:438-62. 2006